Andrew Miller, EVP, CFO at CEPHEID (CPHD), sold 5,625 shares at $54.75 ($308K) on 2014-11-13, disclosed to the SEC on 2014-11-17.
Scheduled sale ($308k) by EVP, CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IRBT | SELL | 2020-12-11 | $137K | — | Filing → |
| IRBT | SELL | 2020-06-09 | $74K | — | Filing → |
| IRBT | SELL | 2019-12-11 | $20K | — | Filing → |